Incidence and Course of Stress Hyperglycemia in Critically Ill Children Admitted to PICU of Assiut University Children Hospital
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Detection of the prevelance of stress hyperglycemia in patients admitted to pediatric intensive care unit of Assiut university children hospital , asses its pattern ,course ,risk factors, its relation to the outcome and its management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedOctober 19, 2020
October 1, 2020
1 year
October 12, 2020
October 12, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Detection of the prevelance of stress hyperglycemia in patients admitted to pediatric intensive care unit of Assiut university children hospital
, asses its pattern ,course ,risk factors, its relation to the outcome and its management
baseline
Eligibility Criteria
Children with blood glucose above 200 mg/dl on admission to the emergency department will be considered to have hyperglycemia. Data will be collected . The blood sugar values will be followed up in these children until restoration of normoglycemia. All the children will be followed up till discharge or death in case of mortality
You may qualify if:
- Critically ill children admitted to emergency and intensive care unit with blood glucose level more than or equal 200 mg\\dl.
You may not qualify if:
- Documented cases of diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- safaa.20124126@med.au.eau.eg
Study Record Dates
First Submitted
October 12, 2020
First Posted
October 19, 2020
Study Start
December 1, 2020
Primary Completion
December 1, 2021
Study Completion
January 1, 2022
Last Updated
October 19, 2020
Record last verified: 2020-10